Our products have been proven to be safe & effective in early studies. We reached our crowdfunding goal of $1.07M and have 1,725 investors on StartEngine. We launched our BEECure ™ R-radiation and laser skin care on Amazon and Walmart.com. Completed testing on our advanced wound care products and will apply for 510(k) pre-market clearance from the FDA in Q2 2021.
Revenue Amount
$30,000,000
Organizations Involved
None
Founders
Kenneth A. Sabacinski, Diana Sabacinski, John Kaufman
Company Description
SanMelix develops advanced homeopathic compositions efficient in the treatment of a variety of wound and dermal afflictions.